Donate today to support women in science at Burnet and their work to unlock the vaginal microbiome and reduce risk of HIV infection and preterm birth for women around the world.
Improving the health of vulnerable communities and changing lives is at the heart of what we do and who we are.
Non-optimal cervicovaginal microbiota is associated with adverse sexual and reproductive health outcomes. However, the nature of the vaginal microbiota in Papua New Guinean women of reproductive age, which can vary depending on race, is unknown.
Furthermore, the role of the vaginal microbiome in protecting against or increasing susceptibility to sexually transmitted infection (STIs), and adverse reproductive health outcomes including preterm delivery and birth weight are unknown in this specific cohort.
This initiative will advance knowledge of the diversity of bacteria colonised in the cervicovagina as well as generate pilot data and build capacity for microbiome research at Burnet.
2019
For any general enquiries relating to this project, please contact:
Head of Life Sciences; Head of Tachedjian Laboratory (Retroviral Biology and Antivirals)
To create and translate knowledge into better health, so no-one is left behind.
85 Commercial Road, Melbourne
VIC, 3004, Australia
Receive updates and IMPACT magazine.
Copyright © 2023 Burnet Institute. ABN: 49 007 349 984
This website was developed with the generous support of a donor.
Burnet Institute (Australia) is located on the traditional land of the Boon Wurrung people and we offer our respects to their Elders past and present.
We recognise and respect the continuation of cultural, spiritual and educational practices of Aboriginal and Torres Strait Islander peoples of this land.
